Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Glostrup Kiropraktisk Klinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.3% 2.5% 3.2% 1.1% 0.8% 0.8% 9.9% 9.9%   Credit score (0-100)   83 63 56 83 91 90 25 25   Credit rating   A BBB BBB A AA AA BB BB   Credit limit (kDKK)   53.3 0.0 0.0 192.6 335.4 367.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,771 2,590 2,120 2,467 2,595 2,935 0.0 0.0   EBITDA   1,192 678 807 1,066 890 804 0.0 0.0   EBIT   1,130 588 728 941 818 728 0.0 0.0   Pre-tax profit (PTP)   1,391.8 73.3 -399.7 3,470.6 990.8 1,164.4 0.0 0.0   Net earnings   1,152.3 54.6 -313.0 3,002.9 763.8 896.3 0.0 0.0   Pre-tax profit without non-rec. items   1,392 73.3 -400 3,471 991 1,164 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   295 239 2,843 2,718 2,713 2,637 0.0 0.0   Shareholders equity total   1,944 1,199 886 3,889 3,152 3,299 2,374 2,374   Interest-bearing liabilities   631 1,310 2,818 2,048 1,460 1,097 0.0 0.0   Balance sheet total (assets)   3,039 2,783 4,232 6,561 5,127 4,910 2,374 2,374   Net Debt   -1,838 -1,011 1,697 -1,663 1,260 33.3 -2,374 -2,374     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,771 2,590 2,120 2,467 2,595 2,935 0.0 0.0   Gross profit growth   1.5% -6.5% -18.2% 16.3% 5.2% 13.1% -100.0% 0.0%   Employees   3 3 3 3 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,039 2,783 4,232 6,561 5,127 4,910 2,374 2,374   Balance sheet change%   3.2% -8.4% 52.1% 55.0% -21.9% -4.2% -51.7% 0.0%   Added value   1,192.4 677.8 806.5 1,066.4 943.6 803.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -48 -146 2,526 -251 -77 -151 -2,637 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   40.8% 22.7% 34.3% 38.1% 31.5% 24.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   49.7% 24.5% 20.8% 66.1% 31.1% 24.4% 0.0% 0.0%   ROI %   57.3% 27.5% 23.4% 74.0% 34.5% 27.2% 0.0% 0.0%   ROE %   69.1% 3.5% -30.0% 125.8% 21.7% 27.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   64.0% 43.5% 21.1% 59.6% 61.5% 67.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -154.2% -149.2% 210.4% -156.0% 141.6% 4.1% 0.0% 0.0%   Gearing %   32.5% 109.3% 318.1% 52.7% 46.3% 33.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.4% 64.5% 54.7% 4.1% 47.2% 4.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.5 1.6 0.7 2.6 2.7 3.9 0.0 0.0   Current Ratio   2.5 1.6 0.7 2.5 2.7 3.9 0.0 0.0   Cash and cash equivalent   2,469.8 2,321.2 1,120.9 3,711.8 199.8 1,063.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -875.2 -1,420.0 -1,824.8 -1,157.6 1,338.8 1,108.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   397 226 269 355 236 201 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   397 226 269 355 222 201 0 0   EBIT / employee   377 196 243 314 205 182 0 0   Net earnings / employee   384 18 -104 1,001 191 224 0 0